Literature DB >> 10361516

Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy.

B F Skinnider1, E C Jones.   

Abstract

Chromophobe renal cell carcinoma (RCC) is characterized by diffuse cytoplasmic staining with Hale colloidal iron (HCI) and the presence of numerous microvesicles. The eosinophilic variant morphologically may resemble renal oncocytoma. The latter commonly shows focal cytoplasmic HCI reactivity, but microvesicles have not been previously reported. We examined 19 chromophobe RCCs and 28 oncocytomas for their HCI staining patterns. Electron microscopy was performed on 13 chromophobe RCCs and 10 oncocytomas. In all cases of chromophobe RCC, more than 75% of cells showed a diffuse cytoplasmic HCI positivity, whereas a variable proportion of cells in 20 oncocytomas showed focal cytoplasmic staining, in a perimembranous, apical, or perinuclear pattern. Ultrastructurally, chromophobe RCCs contained abundant microvesicles with varying numbers of mitochondria, whereas all oncocytomas contained abundant mitochondria with focal collections of microvesicles. The microvesicles, in perimembranous, apical, or perinuclear clusters or singly scattered throughout the cytoplasm, were morphologically indistinguishable from those in chromophobe RCCs. In most cases, the microvesicle location and HCI staining pattern correlated. Chromophobe RCC and oncocytoma have distinctive morphologic features that usually allow their recognition. In difficult cases, HCI staining and electron microscopy may help, but the presence of HCI positivity or microvesicles in an eosinophilic renal tumor does not rule out oncocytoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361516     DOI: 10.1093/ajcp/111.6.796

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.

Authors:  Ozgur Mete; Isin Kilicaslan; Mine G Gulluoglu; Veli Uysal
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

2.  Chromophobe renal cell carcinoma with prominent lymph node metastasis and polysomy of chromosome 21: poorly differentiated form or "presarcomatoid" form?

Authors:  Naoto Kuroda; Masato Tamura; Ondrej Hes; Michal Michal; Taro Shuin; Makoto Toi; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

3.  Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

Authors:  John P T Higgins; Rajesh Shinghal; Harcharan Gill; Jeffrey H Reese; Martha Terris; Ronald J Cohen; Michael Fero; Jonathan R Pollack; Matt van de Rijn; James D Brooks
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

4.  Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria.

Authors:  B Walter; A Hartmann; F Hofstädter; K Junker; H Moch; S Bertz; S Denzinger; W Otto; M Gajda; C G Stoehr
Journal:  Virchows Arch       Date:  2012-02-17       Impact factor: 4.064

Review 5.  Update on oncocytoma.

Authors:  Stephen M Schatz; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

6.  High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms.

Authors:  Kazunori Kanehira; Johnny Hu; Thomas Pier; Linda Sebree; Wei Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Differential expression of a new isoform of DLG2 in renal oncocytoma.

Authors:  Dmitry Zubakov; Zorica Stupar; Gyula Kovacs
Journal:  BMC Cancer       Date:  2006-04-26       Impact factor: 4.430

8.  MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis.

Authors:  R M Silva-Santos; P Costa-Pinheiro; A Luis; L Antunes; F Lobo; J Oliveira; R Henrique; C Jerónimo
Journal:  Br J Cancer       Date:  2013-10-15       Impact factor: 7.640

9.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18

10.  Distinct Cytoplasmic Expression of KL-6 Mucin in Chromophobe Renal Cell Carcinoma: A Comparative Immunohistochemical Study with Other Renal Epithelial Cell Tumors.

Authors:  Mana Fukushima; Kayoko Higuchi; Hisashi Shimojo; Takeshi Uehara; Hiroyoshi Ota
Journal:  Acta Histochem Cytochem       Date:  2012-09-11       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.